Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Dissecting Epstein-Barr Virus-Specific T-Cell Responses After Allogeneic EBV-Specific T-Cell Transfer for Central Nervous System Posttransplant Lymphoproliferative Disease.

Schultze-Florey RE, Tischer S, Kuhlmann L, Hundsdoerfer P, Koch A, Anagnostopoulos I, Ravens S, Goudeva L, Schultze-Florey C, Koenecke C, Blasczyk R, Koehl U, Heuft HG, Prinz I, Eiz-Vesper B, Maecker-Kolhoff B.

Front Immunol. 2018 Jun 27;9:1475. doi: 10.3389/fimmu.2018.01475. eCollection 2018.

2.

MicroRNA in T-Cell Development and T-Cell Mediated Acute Graft-Versus-Host Disease.

Koenecke C, Krueger A.

Front Immunol. 2018 May 7;9:992. doi: 10.3389/fimmu.2018.00992. eCollection 2018. Review.

3.

Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells.

Hammer Q, Rückert T, Borst EM, Dunst J, Haubner A, Durek P, Heinrich F, Gasparoni G, Babic M, Tomic A, Pietra G, Nienen M, Blau IW, Hofmann J, Na IK, Prinz I, Koenecke C, Hemmati P, Babel N, Arnold R, Walter J, Thurley K, Mashreghi MF, Messerle M, Romagnani C.

Nat Immunol. 2018 May;19(5):453-463. doi: 10.1038/s41590-018-0082-6. Epub 2018 Apr 9.

PMID:
29632329
4.

Human γδ T Cell Receptor Repertoires in Peripheral Blood Remain Stable Despite Clearance of Persistent Hepatitis C Virus Infection by Direct-Acting Antiviral Drug Therapy.

Ravens S, Hengst J, Schlapphoff V, Deterding K, Dhingra A, Schultze-Florey C, Koenecke C, Cornberg M, Wedemeyer H, Prinz I.

Front Immunol. 2018 Mar 16;9:510. doi: 10.3389/fimmu.2018.00510. eCollection 2018.

5.

Publisher Correction: Human γδ T cells are quickly reconstituted after stem-cell transplantation and show adaptive clonal expansion in response to viral infection.

Ravens S, Schultze-Florey C, Raha S, Sandrock I, Drenker M, Oberdörfer L, Reinhardt A, Ravens I, Beck M, Geffers R, von Kaisenberg C, Heuser M, Thol F, Ganser A, Förster R, Koenecke C, Prinz I.

Nat Immunol. 2018 Feb 14. doi: 10.1038/s41590-018-0054-x. [Epub ahead of print]

PMID:
29449629
6.

Outcome of a Salvage Third Autologous Stem Cell Transplantation in Multiple Myeloma.

Garderet L, Iacobelli S, Koster L, Goldschmidt H, Johansson JE, Bourhis JH, Krejci M, Leleu X, Potter M, Blaise D, Koenecke C, Peschel C, Radocha J, Metzner B, Lenain P, Schäfer-Eckart K, Pohlreich D, Grasso M, Caillot D, Einsele H, Ladetto M, Schönland S, Kröger N.

Biol Blood Marrow Transplant. 2018 Jul;24(7):1372-1378. doi: 10.1016/j.bbmt.2018.01.035. Epub 2018 Feb 3.

PMID:
29408334
7.

Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation: a retrospective analysis of the EBMT chronic malignancies working party.

Scheid C, de Wreede L, van Biezen A, Koenecke C, Göhring G, Volin L, Maertens J, Finke J, Passweg J, Beelen D, Cornelissen JJ, Itälä-Remes M, Chevallier P, Russell N, Petersen E, Milpied N, Richard Espiga C, Peniket A, Sierra J, Mufti G, Crawley C, Veelken JH, Ljungman P, Cahn JY, Alessandrino EP, de Witte T, Robin M, Kröger N.

Bone Marrow Transplant. 2017 Nov;52(11):1519-1525. doi: 10.1038/bmt.2017.171. Epub 2017 Sep 11.

8.

Characterization of High-Avidity Cytomegalovirus-Specific T Cells with Differential Tetramer Binding Coappearing after Allogeneic Stem Cell Transplantation.

Ogonek J, Verma K, Schultze-Florey C, Varanasi P, Luther S, Schweier P, Kühnau W, Göhring G, Dammann E, Stadler M, Ganser A, Koehl U, Koenecke C, Weissinger EM, Hambach L.

J Immunol. 2017 Jul 15;199(2):792-805. doi: 10.4049/jimmunol.1601992. Epub 2017 Jun 19.

9.

Individual outcome prediction for myelodysplastic syndrome (MDS) and secondary acute myeloid leukemia from MDS after allogeneic hematopoietic cell transplantation.

Heuser M, Gabdoulline R, Löffeld P, Dobbernack V, Kreimeyer H, Pankratz M, Flintrop M, Liebich A, Klesse S, Panagiota V, Stadler M, Wichmann M, Shahswar R, Platzbecker U, Thiede C, Schroeder T, Kobbe G, Geffers R, Schlegelberger B, Göhring G, Kreipe HH, Germing U, Ganser A, Kröger N, Koenecke C, Thol F.

Ann Hematol. 2017 Aug;96(8):1361-1372. doi: 10.1007/s00277-017-3027-5. Epub 2017 Jun 13.

PMID:
28612220
10.

Impact of Molecular Genetics on Outcome in Myelofibrosis Patients after Allogeneic Stem Cell Transplantation.

Kröger N, Panagiota V, Badbaran A, Zabelina T, Triviai I, Araujo Cruz MM, Shahswar R, Ayuk F, Gehlhaar M, Wolschke C, Bollin R, Walter C, Dugas M, Wiehlmann L, Lehmann U, Koenecke C, Chaturvedi A, Alchalby H, Stadler M, Eder M, Christopeit M, Göhring G, Koenigsmann M, Schlegelberger B, Kreipe HH, Ganser A, Stocking C, Fehse B, Thol F, Heuser M.

Biol Blood Marrow Transplant. 2017 Jul;23(7):1095-1101. doi: 10.1016/j.bbmt.2017.03.034. Epub 2017 Apr 4.

11.

Human γδ T cells are quickly reconstituted after stem-cell transplantation and show adaptive clonal expansion in response to viral infection.

Ravens S, Schultze-Florey C, Raha S, Sandrock I, Drenker M, Oberdörfer L, Reinhardt A, Ravens I, Beck M, Geffers R, von Kaisenberg C, Heuser M, Thol F, Ganser A, Förster R, Koenecke C, Prinz I.

Nat Immunol. 2017 Apr;18(4):393-401. doi: 10.1038/ni.3686. Epub 2017 Feb 20. Erratum in: Nat Immunol. 2018 Feb 14;:.

PMID:
28218745
12.

VH1 Family Immunoglobulin Repertoire Sequencing after Allogeneic Hematopoietic Stem Cell Transplantation.

Sethi MK, Thol F, Stadler M, Heuser M, Ganser A, Koenecke C, Pabst O.

PLoS One. 2017 Jan 17;12(1):e0168096. doi: 10.1371/journal.pone.0168096. eCollection 2017.

13.

Matched-pair analysis: identification of factors with independent influence on the development of PTLD after kidney or liver transplantation.

Rausch L, Koenecke C, Koch HF, Kaltenborn A, Emmanouilidis N, Pape L, Lehner F, Arelin V, Baumann U, Schrem H.

Transplant Res. 2016 Aug 2;5:6. doi: 10.1186/s13737-016-0036-1. eCollection 2016.

14.

Disruption of de novo fatty acid synthesis via acetyl-CoA carboxylase 1 inhibition prevents acute graft-versus-host disease.

Raha S, Raud B, Oberdörfer L, Castro CN, Schreder A, Freitag J, Longerich T, Lochner M, Sparwasser T, Berod L, Koenecke C, Prinz I.

Eur J Immunol. 2016 Sep;46(9):2233-8. doi: 10.1002/eji.201546152. Epub 2016 Jul 18.

15.

Outcome of patients with chronic myeloid leukemia and a low-risk score: allogeneic hematopoietic stem cell transplantation in the era of targeted therapy. A report from the EBMT Chronic Malignancies Working Party.

Koenecke C, Heim D, van Biezen A, Heuser M, Aljurf M, Kyrcz-Krzemien S, Volin L, de Souza CA, Gedde-Dahl T, Sengeloev H, Schanz U, Komarnicki M, Arroyo CH, Tholouli E, Gluckman E, Esquirol A, Yakoub-Agha I, Gürman G, Olavarria E, Kröger N.

Bone Marrow Transplant. 2016 Sep;51(9):1259-61. doi: 10.1038/bmt.2016.97. Epub 2016 Apr 25. No abstract available.

PMID:
27111041
16.

miR-181a Expression in Donor T Cells Modulates Graft-versus-Host Disease after Allogeneic Bone Marrow Transplantation.

Lee CW, Wohlan K, Dallmann I, Förster R, Ganser A, Krueger A, Scherr M, Eder M, Koenecke C.

J Immunol. 2016 May 1;196(9):3927-34. doi: 10.4049/jimmunol.1502152. Epub 2016 Mar 23.

17.

Long-term results of adjuvant donor lymphocyte transfusion in AML after allogeneic stem cell transplantation.

Jedlickova Z, Schmid C, Koenecke C, Hertenstein B, Baurmann H, Schwerdtfeger R, Tischer J, Kolb HJ, Schleuning M.

Bone Marrow Transplant. 2016 May;51(5):663-7. doi: 10.1038/bmt.2015.234. Epub 2015 Oct 5.

PMID:
26437060
18.

Differential Effects of Gut-Homing Molecules CC Chemokine Receptor 9 and Integrin-β7 during Acute Graft-versus-Host Disease of the Liver.

Schreder A, Moschovakis GL, Halle S, Schlue J, Lee CW, Schippers A, David S, Bernhardt G, Ganser A, Pabst O, Förster R, Koenecke C.

Biol Blood Marrow Transplant. 2015 Dec;21(12):2069-2078. doi: 10.1016/j.bbmt.2015.08.038. Epub 2015 Sep 5.

19.

Frequency and prognostic impact of casein kinase 1A1 mutations in MDS patients with deletion of chromosome 5q.

Heuser M, Meggendorfer M, Cruz MM, Fabisch J, Klesse S, Köhler L, Göhring G, Ganster C, Shirneshan K, Gutermuth A, Cerny-Reiterer S, Krönke J, Panagiota V, Haferlach C, Koenecke C, Platzbecker U, Thiede C, Schroeder T, Kobbe G, Ehrlich S, Stamer K, Döhner K, Valent P, Schlegelberger B, Kroeger N, Ganser A, Haase D, Haferlach T, Thol F.

Leukemia. 2015 Sep;29(9):1942-5. doi: 10.1038/leu.2015.49. Epub 2015 Feb 24. No abstract available.

PMID:
25792355
20.

A clonotypic Vγ4Jγ1/Vδ5Dδ2Jδ1 innate γδ T-cell population restricted to the CCR6⁺CD27⁻ subset.

Kashani E, Föhse L, Raha S, Sandrock I, Oberdörfer L, Koenecke C, Suerbaum S, Weiss S, Prinz I.

Nat Commun. 2015 Mar 13;6:6477. doi: 10.1038/ncomms7477.

PMID:
25765849
21.

Allogeneic hematopoietic stem cell transplantation in solid organ transplant recipients: a retrospective, multicenter study of the EBMT.

Basak GW, Wiktor-Jedrzejczak W, Labopin M, Schoemans H, Ljungman P, Kobbe G, Beguin Y, Lang P, Koenecke C, Sykora KW, Te Boome L, van Biezen A, van der Werf S, Mohty M, de Witte T, Marsh J, Dreger P, Kröger N, Duarte R, Ruutu T.

Am J Transplant. 2015 Mar;15(3):705-14. doi: 10.1111/ajt.13017. Epub 2015 Feb 3.

22.

Clinical and functional implications of microRNA mutations in a cohort of 935 patients with myelodysplastic syndromes and acute myeloid leukemia.

Thol F, Scherr M, Kirchner A, Shahswar R, Battmer K, Kade S, Chaturvedi A, Koenecke C, Stadler M, Platzbecker U, Thiede C, Schroeder T, Kobbe G, Bug G, Ottmann O, Hofmann WK, Kröger N, Fiedler W, Schlenk R, Döhner K, Döhner H, Krauter J, Eder M, Ganser A, Heuser M.

Haematologica. 2015 Apr;100(4):e122-4. doi: 10.3324/haematol.2014.120345. Epub 2014 Dec 31. No abstract available.

23.

Impact of the revised International Prognostic Scoring System, cytogenetics and monosomal karyotype on outcome after allogeneic stem cell transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia evolving from myelodysplastic syndromes: a retrospective multicenter study of the European Society of Blood and Marrow Transplantation.

Koenecke C, Göhring G, de Wreede LC, van Biezen A, Scheid C, Volin L, Maertens J, Finke J, Schaap N, Robin M, Passweg J, Cornelissen J, Beelen D, Heuser M, de Witte T, Kröger N; MDS subcommittee of the Chronic Malignancies Working Party of the EBMT.

Haematologica. 2015 Mar;100(3):400-8. doi: 10.3324/haematol.2014.116715. Epub 2014 Dec 31.

24.

Comparison of unrelated cord blood and peripheral blood stem cell transplantation in adults with myelodysplastic syndrome after reduced-intensity conditioning regimen: a collaborative study from Eurocord (Cord blood Committee of Cellular Therapy & Immunobiology Working Party of EBMT) and Chronic Malignancies Working Party.

Robin M, Ruggeri A, Labopin M, Niederwieser D, Tabrizi R, Sanz G, Bourhis JH, van Biezen A, Koenecke C, Blaise D, Tischer J, Craddock C, Maillard N, Mohty M, Russel N, Schetelig J, Finke J, Gluckman E, de Witte TM, Rocha V, Kroger N.

Biol Blood Marrow Transplant. 2015 Mar;21(3):489-95. doi: 10.1016/j.bbmt.2014.11.675. Epub 2014 Dec 19.

25.

Genetic characterization of acquired aplastic anemia by targeted sequencing.

Heuser M, Schlarmann C, Dobbernack V, Panagiota V, Wiehlmann L, Walter C, Beier F, Ziegler P, Yun H, Kade S, Kirchner A, Huang L, Koenecke C, Eder M, Brümmendorf TH, Dugas M, Ganser A, Thol F.

Haematologica. 2014 Sep;99(9):e165-7. doi: 10.3324/haematol.2013.101642. Epub 2014 Jun 6. No abstract available.

26.

Low frequency of calreticulin mutations in MDS patients.

Heuser M, Panagiota V, Koenecke C, Fehse B, Alchalby H, Badbaran A, Shahswar R, Stadler M, Eder M, Göhring G, Trummer A, Schroeder T, Kobbe G, Thiede C, Platzbecker U, Schlegelberger B, Kroeger N, Ganser A, Thol F.

Leukemia. 2014 Sep;28(9):1933-4. doi: 10.1038/leu.2014.165. Epub 2014 May 21. No abstract available.

PMID:
24850292
27.

Prognostic effect of calreticulin mutations in patients with myelofibrosis after allogeneic hematopoietic stem cell transplantation.

Panagiota V, Thol F, Markus B, Fehse B, Alchalby H, Badbaran A, Lehmann U, Koenecke C, Shahswar R, Chaturvedi A, Stadler M, Eder M, Göhring G, Koenigsmann M, Kloos A, Trummer A, Schroeder T, Kobbe G, Thiede C, Platzbecker U, Schlegelberger B, Kreipe HH, Ganser A, Kröger N, Heuser M.

Leukemia. 2014 Jul;28(7):1552-5. doi: 10.1038/leu.2014.66. Epub 2014 Feb 7. No abstract available.

PMID:
24504025
28.

Hepatitis E virus infection in a hematopoietic stem cell donor.

Koenecke C, Pischke S, Beutel G, Ritter U, Ganser A, Wedemeyer H, Eder M.

Bone Marrow Transplant. 2014 Jan;49(1):159-60. doi: 10.1038/bmt.2013.148. Epub 2013 Sep 23. No abstract available.

PMID:
24056741
29.

Donor Vδ1+ γδ T cells expand after allogeneic hematopoietic stem cell transplantation and show reactivity against CMV-infected cells but not against progressing B-CLL.

Prinz I, Thamm K, Port M, Weissinger EM, Stadler M, Gabaev I, Jacobs R, Ganser A, Koenecke C.

Exp Hematol Oncol. 2013 May 11;2(1):14. doi: 10.1186/2162-3619-2-14.

30.

SETBP1 mutation analysis in 944 patients with MDS and AML.

Thol F, Suchanek KJ, Koenecke C, Stadler M, Platzbecker U, Thiede C, Schroeder T, Kobbe G, Kade S, Löffeld P, Banihosseini S, Bug G, Ottmann O, Hofmann WK, Krauter J, Kröger N, Ganser A, Heuser M.

Leukemia. 2013 Oct;27(10):2072-5. doi: 10.1038/leu.2013.145. Epub 2013 May 7. No abstract available.

PMID:
23648668
31.

IFN-γ production by allogeneic Foxp3+ regulatory T cells is essential for preventing experimental graft-versus-host disease.

Koenecke C, Lee CW, Thamm K, Föhse L, Schafferus M, Mittrücker HW, Floess S, Huehn J, Ganser A, Förster R, Prinz I.

J Immunol. 2012 Sep 15;189(6):2890-6. doi: 10.4049/jimmunol.1200413. Epub 2012 Aug 6.

32.

Shift of graft-versus-host-disease target organ tropism by dietary vitamin A.

Koenecke C, Prinz I, Bubke A, Schreder A, Lee CW, Pabst O, Förster R.

PLoS One. 2012;7(5):e38252. doi: 10.1371/journal.pone.0038252. Epub 2012 May 30.

33.

Superiority of the triple combination of bortezomib-thalidomide-dexamethasone over the dual combination of thalidomide-dexamethasone in patients with multiple myeloma progressing or relapsing after autologous transplantation: the MMVAR/IFM 2005-04 Randomized Phase III Trial from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

Garderet L, Iacobelli S, Moreau P, Dib M, Lafon I, Niederwieser D, Masszi T, Fontan J, Michallet M, Gratwohl A, Milone G, Doyen C, Pegourie B, Hajek R, Casassus P, Kolb B, Chaleteix C, Hertenstein B, Onida F, Ludwig H, Ketterer N, Koenecke C, van Os M, Mohty M, Cakana A, Gorin NC, de Witte T, Harousseau JL, Morris C, Gahrton G.

J Clin Oncol. 2012 Jul 10;30(20):2475-82. doi: 10.1200/JCO.2011.37.4918. Epub 2012 May 14. Erratum in: J Clin Oncol. 2012 Sep 20;30(27):3429. J Clin Oncol. 2014 Apr 20;32(12):1285.

PMID:
22585692
34.

Therapeutic potential of induced and natural FoxP3(+) regulatory T cells for the treatment of Graft-versus-host disease.

Prinz I, Koenecke C.

Arch Immunol Ther Exp (Warsz). 2012 Jun;60(3):183-90. doi: 10.1007/s00005-012-0172-3. Epub 2012 Apr 5. Review.

PMID:
22476537
35.

Chronic hepatitis E in hematopoietic stem cell transplant patients in a low-endemic country?

Koenecke C, Pischke S, Heim A, Raggub L, Bremer B, Raupach R, Buchholz S, Schulz T, Manns MP, Ganser A, Wedemeyer H.

Transpl Infect Dis. 2012 Feb;14(1):103-6. doi: 10.1111/j.1399-3062.2011.00702.x. Epub 2011 Dec 28.

PMID:
22212560
36.

High TCR diversity ensures optimal function and homeostasis of Foxp3+ regulatory T cells.

Föhse L, Suffner J, Suhre K, Wahl B, Lindner C, Lee CW, Schmitz S, Haas JD, Lamprecht S, Koenecke C, Bleich A, Hämmerling GJ, Malissen B, Suerbaum S, Förster R, Prinz I.

Eur J Immunol. 2011 Nov;41(11):3101-13. doi: 10.1002/eji.201141986. Epub 2011 Oct 18.

37.

Acute administration of recombinant Angiopoietin-1 ameliorates multiple-organ dysfunction syndrome and improves survival in murine sepsis.

David S, Park JK, Meurs Mv, Zijlstra JG, Koenecke C, Schrimpf C, Shushakova N, Gueler F, Haller H, Kümpers P.

Cytokine. 2011 Aug;55(2):251-9. doi: 10.1016/j.cyto.2011.04.005. Epub 2011 Apr 30.

PMID:
21531574
38.

Absence of CD155 aggravates acute graft-versus-host disease.

Seth S, Ravens I, Lee CW, Glage S, Bleich A, Förster R, Bernhardt G, Koenecke C.

Proc Natl Acad Sci U S A. 2011 Mar 8;108(10):E32-3; author reply E34. doi: 10.1073/pnas.1017969108. Epub 2011 Feb 14. No abstract available.

39.

Biopsy-diagnosed renal disease in patients after transplantation of other organs and tissues.

Schwarz A, Haller H, Schmitt R, Schiffer M, Koenecke C, Strassburg C, Lehner F, Gottlieb J, Bara C, Becker JU, Broecker V.

Am J Transplant. 2010 Sep;10(9):2017-25. doi: 10.1111/j.1600-6143.2010.03224.x.

40.

Solid organ transplantation after allogeneic hematopoietic stem cell transplantation: a retrospective, multicenter study of the EBMT.

Koenecke C, Hertenstein B, Schetelig J, van Biezen A, Dammann E, Gratwohl A, Ganser A, Schleuning M, Bornhäuser M, Jacobsen N, Kröger N, Niederwieser D, de Witte T, Ruutu T.

Am J Transplant. 2010 Aug;10(8):1897-906. doi: 10.1111/j.1600-6143.2010.03187.x.

41.

Shedding of the endothelial receptor tyrosine kinase Tie2 correlates with leukemic blast burden and outcome after allogeneic hematopoietic stem cell transplantation for AML.

Koenecke C, Kümpers P, Lukasz A, Dammann E, Verhagen W, Göhring G, Buchholz S, Krauter J, Eder M, Schlegelberger B, Ganser A.

Ann Hematol. 2010 May;89(5):459-67. doi: 10.1007/s00277-009-0869-5.

PMID:
20054548
42.

Prolonged isolated red blood cell transfusion requirement after allogeneic blood stem cell transplantation: identification of patients at risk.

Dahl D, Hahn A, Koenecke C, Heuft HG, Dammann E, Stadler M, Buchholz S, Krauter J, Eder M, Sykora KW, Klein C, Ganser A, Sauer M.

Transfusion. 2010 Mar;50(3):649-55. doi: 10.1111/j.1537-2995.2009.02461.x. Epub 2009 Nov 19.

PMID:
19929861
43.

Alloantigen-specific de novo-induced Foxp3+ Treg revert in vivo and do not protect from experimental GVHD.

Koenecke C, Czeloth N, Bubke A, Schmitz S, Kissenpfennig A, Malissen B, Huehn J, Ganser A, Förster R, Prinz I.

Eur J Immunol. 2009 Nov;39(11):3091-6. doi: 10.1002/eji.200939432.

44.

Mesenteric lymph nodes confine dendritic cell-mediated dissemination of Salmonella enterica serovar Typhimurium and limit systemic disease in mice.

Voedisch S, Koenecke C, David S, Herbrand H, Förster R, Rhen M, Pabst O.

Infect Immun. 2009 Aug;77(8):3170-80. doi: 10.1128/IAI.00272-09. Epub 2009 Jun 8.

45.

CCR9 and inflammatory bowel disease.

Koenecke C, Förster R.

Expert Opin Ther Targets. 2009 Mar;13(3):297-306. doi: 10.1517/14728220902762928 . Review.

PMID:
19236152
46.

Donor T cells primed on leukemia lysate-pulsed recipient APCs mediate strong graft-versus-leukemia effects across MHC barriers in full chimeras.

Ghosh A, Koestner W, Hapke M, Schlaphoff V, Länger F, Baumann R, Koenecke C, Cornberg M, Welte K, Blazar BR, Sauer MG.

Blood. 2009 Apr 30;113(18):4440-8. doi: 10.1182/blood-2008-09-181677. Epub 2009 Jan 30.

47.

T helper type 2 differentiation is associated with induction of antibacterial defense mechanisms in blood lymphocytes of patients with sarcoidosis.

Ukena SN, Koenecke C, Geffers R, Fuehner T, Welte T, Ganser A, Buer J, Franzke A.

Immunol Invest. 2009;38(1):49-66. doi: 10.1080/08820130802572103.

PMID:
19172485
48.

In vivo application of mAb directed against the gammadelta TCR does not deplete but generates "invisible" gammadelta T cells.

Koenecke C, Chennupati V, Schmitz S, Malissen B, Förster R, Prinz I.

Eur J Immunol. 2009 Feb;39(2):372-9. doi: 10.1002/eji.200838741.

49.

High-affinity neurotrophin receptors and ligands promote leukemogenesis.

Li Z, Beutel G, Rhein M, Meyer J, Koenecke C, Neumann T, Yang M, Krauter J, von Neuhoff N, Heuser M, Diedrich H, Göhring G, Wilkens L, Schlegelberger B, Ganser A, Baum C.

Blood. 2009 Feb 26;113(9):2028-37. doi: 10.1182/blood-2008-05-155200. Epub 2008 Dec 4.

50.

Rituximab as rescue therapy in anti-neutrophil cytoplasmic antibody-associated vasculitis: a single-centre experience with 15 patients.

Lovric S, Erdbruegger U, Kümpers P, Woywodt A, Koenecke C, Wedemeyer H, Haller H, Haubitz M.

Nephrol Dial Transplant. 2009 Jan;24(1):179-85. doi: 10.1093/ndt/gfn430. Epub 2008 Aug 6.

PMID:
18685144

Supplemental Content

Loading ...
Support Center